Foundation Medicine, a leader in molecular insights, has joined the Roche Group to enhance understanding of tumors, facilitate smarter research and development, and improve patient care through comprehensive genomic profiling services. This collaboration combines Roche's expertise in oncology with Foundation Medicine's technology and experience in cancer profiling to provide insights on clinical trials, personalized treatment strategies, and relevant therapies for cancer patients.